Circulating Tumor DNA May Identify Treatment Response in Colon Cancer - Genetic Engineering & Biotechnology News
6/6/2022 12:00:00 AM2 years 11 months ago
by Christina Jackson
by Christina Jackson
A new research study led by scientists at the Johns Hopkins Kimmel Cancer Center and WEHI demonstrates that circulating tumor DNA (ctDNA) can identify stage II colon cancer patients who can most benefit from chemotherapy following surgery.
A new research study led by scientists at the Johns Hopkins Kimmel Cancer Center and WEHI demonstrates that circulating tumor DNA (ctDNA) can identify stage II colon cancer patients who can most bene… [+4418 chars]
full article...